Patient Management

CURATED BY: Jessica Jones,
DHSc, PA-C, CAQ-Psych
The Tardive Dyskinesia Impact Scale (TDIS) is a patient-reported outcome tool designed to assess how tardive dyskinesia (TD) affects patients’ daily lives—including physical function, emotional well-being, and social...

Patient Management Guidelines

Consensus Input on Assessing the Impact of Tardive Dyskinesia

An advisory panel developed consensus recommendations on the assessment of the functional impact of tardive dyskinesia in clinical settings.

CURATED BY:
Angela C. Combs,
MN, ARNP, PMHNP-BC

Treatment Recommendations

Using the American Academy of Neurology Risk of Bias Classification system and Scottish Intercollegiate Guidelines Network framework, researchers performed a systematic review of studies on the treatment of tardive dyskinesia and provide treatment recommendations.

CURATED BY:
Angela C. Combs,
MN, ARNP, PMHNP-BC

American Academy of Neurology

An evidence-based guideline from the American Academy of Neurology provides treatment recommendations for tardive syndromes, as well as a treatment algorithm.

CURATED BY:
Angela C. Combs,
MN, ARNP, PMHNP-BC

American Psychiatric Association Practice Guideline

Presented in a standardized format, the American Psychiatric Association practice guidelines provide evidence-based recommendations for the assessment and treatment of psychiatric disorders.

CURATED BY:
Angela C. Combs,
MN, ARNP, PMHNP-BC

Articles

Study Finds Tardive Dyskinesia Movements Lead to Social and Professional Stigma

Tardive dyskinesia (TD) is a potentially irreversible movement disorder caused by antipsychotic medications, marked by involuntary, repetitive movements that can...
CURATED BY:
Jessica Jones,
DHSc, PA-C, CAQ-Psych

Study Reveals Underdiagnosis of Tardive Dyskinesia and Disparities in Clinical Recognition

Tardive dyskinesia (TD), a persistent involuntary movement disorder linked to long-term antipsychotic use, is often underreported or misdiagnosed in routine...
CURATED BY:
Jon Falletta,
PA-C, CAQ-Psych

Prevalence and Risk Factors of Tardive Dyskinesia in Patients With Schizophrenia on Antipsychotics

A recent study explored the prevalence and risk factors for tardive dyskinesia (TD) in patients with schizophrenia undergoing long-term antipsychotic...
CURATED BY:
Jon Falletta,
PA-C, CAQ-Psych

Higher Antipsychotic Doses Tied to Increased Risk of Tardive Dyskinesia

Tardive dyskinesia (TD) is a serious, often irreversible movement disorder caused by long-term use of dopamine receptor antagonists, particularly antipsychotics....
CURATED BY:
Aaron Zalewski,
MSN, PMHNP-BC

Clarifying the Language of Tardive Syndromes: A Call for Consistency in Diagnosis and Care

Tardive dyskinesia (TD) was first identified in the 1950s as involuntary oral and facial movements linked to prolonged chlorpromazine use....
CURATED BY:
Jon Falletta,
PA-C, CAQ-Psych

Neuroinflammation Implicated in Tardive Dyskinesia Pathogenesis

Emerging research suggests that immune system dysregulation may play a role in the development of tardive dyskinesia (TD), a movement...
CURATED BY:
Jessica Jones,
DHSc, PA-C, CAQ-Psych
Share